20 participants
Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-12-02
- Start Date:
- 2020-04-30
- Completion:
- 2020-09-30
Conditions
- Cytokine Release Syndrome
- COVID19
Interventions
- PROCEDURE
- DRUG